Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH Issues Ten-Year Strategic Plan For Diabetes Research

This article was originally published in The Gray Sheet

Executive Summary

The National Institutes of Health has mapped out a new strategic plan to guide diabetes research during the next decade. Among the priorities: developing artificial pancreas technologies and identifying genetic factors that influence susceptibility to diabetes and its complications.

You may also be interested in...



Provider Shortage Could Curtail Health Reform Gains For Diabetics

The U.S. health care reform law and its insurance coverage expansion will help improve the lives of patients with diabetes, but an ongoing provider shortage threatens to counter any positive effect, analysts warn.

Novartis In Line For Ofatumumab MS Approval In June

Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.

Topics

UsernamePublicRestriction

Register

MT029979

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel